Natural Killer (NK) cell regulation of antiviral T cell responses in the pathogenesis of HIV infection
HIV 感染发病机制中自然杀伤 (NK) 细胞对抗病毒 T 细胞反应的调节
基本信息
- 批准号:MR/M008614/2
- 负责人:
- 金额:$ 45.7万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Fellowship
- 财政年份:2017
- 资助国家:英国
- 起止时间:2017 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Around 40 million people are currently living with HIV around the globe. HIV remains a leading infectious killer in the world having claimed in excess of 36 million lives to date. Infection with HIV targets the immune system and leads to progressive deterioration of people's ability to survey for and fend off infections and some types of cancer. As the virus impairs and destroys the function of immune cells, affected individuals become gradually more immunocompromised. The most advanced stage of HIV infection is AIDS. Although there is no cure for HIV to date, combination therapy with anti-HIV agents called antiretroviral therapy (ART), prevents the virus from multiplying in the body but cannot eradicate it, stalling the destruction of the body's immune cells. Although effective treatment has resulted in obvious health benefits, accumulating toxicity as a result of lifelong therapy and universal access to therapy are remaining concerns. In addition, ongoing activation of the immune system as seen in treated individuals accounts for a significant proportion of non-AIDS health problems and associated deaths. There is therefore a widely acknowledged need for the development of new and innovative treatments to improve current therapies.The main immune cell type fighting the virus, the T cell, is severely impaired and debilitated during chronic infection. In this study we will be investigating the ability of another type of cell called Natural Killer (NK) cell, to kill the beneficial T cells limiting their antiviral potential. Malfunctioning NK cells may also attack healthy T cells, causing chronic disease instead of fighting it.The purpose of this study is to identify the possible NK cell-mediated pathways leading to T cell deletion. We will use blood samples obtained during routine clinical care of patients infected with HIV following informed consent. Blocking these harmful pathways will boost the immune system leading to improved viral control and prevention of chronic disease and complications.
目前全球约有4000万人感染艾滋病毒。艾滋病毒仍然是世界上主要的传染病杀手,迄今已夺去3 600多万人的生命。艾滋病毒感染的目标是免疫系统,导致人们调查和抵御感染和某些类型癌症的能力逐渐恶化。由于病毒损害和破坏免疫细胞的功能,受感染的个体逐渐变得免疫功能低下。HIV感染的最晚期是艾滋病。尽管到目前为止还没有治愈艾滋病的方法,但与抗艾滋病病毒药物(称为抗逆转录病毒疗法(ART))的联合治疗可以防止病毒在体内繁殖,但不能根除它,从而延缓了对人体免疫细胞的破坏。尽管有效的治疗带来了明显的健康益处,但由于终身治疗和普遍获得治疗而累积的毒性仍然是令人关切的问题。此外,在接受治疗的个体中,免疫系统的持续激活占非艾滋病健康问题和相关死亡的很大一部分。因此,人们普遍认为需要开发新的和创新的治疗方法来改进现有的治疗方法。对抗病毒的主要免疫细胞类型,T细胞,在慢性感染期间严重受损和衰弱。在这项研究中,我们将研究另一种称为自然杀伤细胞(NK)的细胞杀死有益T细胞的能力,这种细胞会限制它们的抗病毒潜力。失灵的NK细胞也可能攻击健康的T细胞,导致慢性疾病,而不是与之抗争。本研究的目的是确定NK细胞介导的可能导致T细胞缺失的途径。我们将使用在艾滋病毒感染者知情同意的常规临床护理期间获得的血液样本。阻断这些有害途径将增强免疫系统,从而改善病毒控制,预防慢性疾病和并发症。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial Dysfunction.
- DOI:10.3389/fimmu.2022.908697
- 发表时间:2022
- 期刊:
- 影响因子:7.3
- 作者:
- 通讯作者:
Seeing SARS-CoV-2 variants through the eyes of T cells.
- DOI:10.1038/s41577-021-00551-w
- 发表时间:2021-05
- 期刊:
- 影响因子:0
- 作者:Alrubayyi A;Peppa D
- 通讯作者:Peppa D
RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses.
- DOI:10.1016/j.cell.2018.08.064
- 发表时间:2018-10-04
- 期刊:
- 影响因子:64.5
- 作者:Bradley T;Peppa D;Pedroza-Pacheco I;Li D;Cain DW;Henao R;Venkat V;Hora B;Chen Y;Vandergrift NA;Overman RG;Edwards RW;Woods CW;Tomaras GD;Ferrari G;Ginsburg GS;Connors M;Cohen MS;Moody MA;Borrow P;Haynes BF
- 通讯作者:Haynes BF
Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy.
- DOI:10.1097/qad.0000000000003319
- 发表时间:2022-11-15
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Subordinate effect of -21M HLA-B dimorphism on NK cell repertoire diversity and function in HIV-1 infected individuals of African origin
-21M HLA-B 二态性对非洲血统 HIV-1 感染者 NK 细胞库多样性和功能的从属影响
- DOI:10.1101/786392
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Cubero E
- 通讯作者:Cubero E
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dimitra Peppa其他文献
Impaired innate immune responses in patients with chronic HBV infection
- DOI:
10.1016/j.jinf.2008.09.014 - 发表时间:
2008-11-01 - 期刊:
- 影响因子:
- 作者:
Dimitra Peppa;Claire Dunn;Celeste Pallant;Abhishek Das;Gidon Ellis;Richard Gilson;Mala Maini - 通讯作者:
Mala Maini
WED-202 - High prevalence of hepatic steatosis in adults living with hepatitis B, with and without HIV co-infection, in London, UK
- DOI:
10.1016/s0168-8278(23)03243-9 - 发表时间:
2023-06-01 - 期刊:
- 影响因子:
- 作者:
Claire Mullender;Angieszka Kemper;Stephen Ogunnaike;Sarah Pett;Irfaan Maan;Manik Kohli;Dimitra Peppa;Alejandro Arenas-Pinto;Stuart Flanagan;Indrajit Ghosh;Richard Gilson;Philippa Matthews - 通讯作者:
Philippa Matthews
In Vivo Generation of Memory-like NK Cells for the Treatment of AML and Myelodysplastic Syndrome; Early Clinical Applications of INKmunesupTM/sup
体内生成记忆样自然杀伤细胞用于治疗急性髓系白血病和骨髓增生异常综合征;INKmune TM 的早期临床应用
- DOI:
10.1182/blood-2022-166175 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:23.100
- 作者:
Kim H. Orchard;Helena Ballestero;Aga Zubiak;Chris Dalley;Deborah Susan Richardson;Rob Torrance;Trinity Eales;Dimitra Peppa;May Sabry;Mark W. Lowdell - 通讯作者:
Mark W. Lowdell
In Vivo Generation of Memory-like NK Cells for the Treatment of AML and Myelodysplastic Syndrome; Early Clinical Applications of INKmune<sup>TM</sup>
- DOI:
10.1182/blood-2022-166175 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Kim H. Orchard;Helena Ballestero;Aga Zubiak;Chris Dalley;Deborah Susan Richardson;Rob Torrance;Trinity Eales;Dimitra Peppa;May Sabry;Mark W. Lowdell - 通讯作者:
Mark W. Lowdell
Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
胰腺导管腺癌(PDAC)中不同的免疫细胞浸润模式表现出不同的免疫细胞选择和免疫抑制机制
- DOI:
10.1038/s41467-024-55424-2 - 发表时间:
2025-02-06 - 期刊:
- 影响因子:15.700
- 作者:
Shivan Sivakumar;Ashwin Jainarayanan;Edward Arbe-Barnes;Piyush Kumar Sharma;Maire Ni Leathlobhair;Sakina Amin;David J. Reiss;Lara Heij;Samarth Hegde;Assaf Magen;Felicia Tucci;Bo Sun;Shihong Wu;Nithishwer Mouroug Anand;Hubert Slawinski;Santiago Revale;Isar Nassiri;Jonathon Webber;Gerard D. Hoeltzel;Adam E. Frampton;Georg Wiltberger;Ulf Neumann;Philip Charlton;Laura Spiers;Tim Elliott;Maria Wang;Suzana Couto;Thomas Lila;Pallavur V. Sivakumar;Alexander V. Ratushny;Mark R. Middleton;Dimitra Peppa;Benjamin Fairfax;Miriam Merad;Michael L. Dustin;Enas Abu-Shah;Rachael Bashford-Rogers - 通讯作者:
Rachael Bashford-Rogers
Dimitra Peppa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dimitra Peppa', 18)}}的其他基金
Natural Killer (NK) cell regulation of antiviral T cell responses in the pathogenesis of HIV infection
HIV 感染发病机制中自然杀伤 (NK) 细胞对抗病毒 T 细胞反应的调节
- 批准号:
MR/M008614/1 - 财政年份:2015
- 资助金额:
$ 45.7万 - 项目类别:
Fellowship
Pathogenic Interaction between Natural Killer (NK) and T cells in chronic Hepatitis B Virus Infection
慢性乙型肝炎病毒感染中自然杀伤 (NK) 和 T 细胞之间的致病相互作用
- 批准号:
G0902009/1 - 财政年份:2010
- 资助金额:
$ 45.7万 - 项目类别:
Fellowship
相似海外基金
SBIR Phase I: Epigenetic Remodeling of Natural Killer (NK) Cells for Blood Cancer Therapies
SBIR 第一阶段:用于血癌治疗的自然杀伤 (NK) 细胞的表观遗传重塑
- 批准号:
2303792 - 财政年份:2023
- 资助金额:
$ 45.7万 - 项目类别:
Standard Grant
Pancreatic Stellate Cell (PSC) Engagement of Natural Killer (NK) cells in the Pancreatic Ductal Adenocarcinoma (PDAC) Tumor Microenvironment
胰腺星状细胞 (PSC) 与胰腺导管腺癌 (PDAC) 肿瘤微环境中自然杀伤 (NK) 细胞的参与
- 批准号:
10704009 - 财政年份:2022
- 资助金额:
$ 45.7万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 45.7万 - 项目类别:
Pancreatic Stellate Cell (PSC) Engagement of Natural Killer (NK) cells in the Pancreatic Ductal Adenocarcinoma (PDAC) Tumor Microenvironment
胰腺星状细胞 (PSC) 与胰腺导管腺癌 (PDAC) 肿瘤微环境中自然杀伤 (NK) 细胞的参与
- 批准号:
10386315 - 财政年份:2022
- 资助金额:
$ 45.7万 - 项目类别:
Natural Killer (NK) Cell Immunotherapy Towards Adult T Cell Leukemia (ATL) via Exaltation of MICA/B Expression and Augments NK Cytotoxicity
通过提高 MICA/B 表达和增强 NK 细胞毒性来治疗成人 T 细胞白血病 (ATL) 的自然杀伤 (NK) 细胞免疫疗法
- 批准号:
22K16327 - 财政年份:2022
- 资助金额:
$ 45.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of Molecular Imaging Tools to Monitor the Fate of an Off-The-Shelf Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Immunotherapy
开发分子成像工具来监测现成的嵌合抗原受体自然杀伤 (CAR-NK) 细胞免疫疗法的命运
- 批准号:
444870 - 财政年份:2021
- 资助金额:
$ 45.7万 - 项目类别:
Operating Grants
Metabolic reprogramming of Trimeric APRIL-CAR-engineered Natural Killer (NK) cells to enhance tumor-cell recognition, in vivo persistence and anti-tumor potency in Multiple myeloma
三聚体 APRIL-CAR 工程自然杀伤 (NK) 细胞的代谢重编程可增强多发性骨髓瘤中的肿瘤细胞识别、体内持久性和抗肿瘤效力
- 批准号:
464778766 - 财政年份:2021
- 资助金额:
$ 45.7万 - 项目类别:
WBP Fellowship
Development of Molecular Imaging Tools to Monitor the Fate of an Off-The-Shelf Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Immunotherapy for Breast Cancer
开发分子成像工具来监测现成的嵌合抗原受体自然杀伤 (CAR-NK) 细胞免疫疗法治疗乳腺癌的效果
- 批准号:
443058 - 财政年份:2020
- 资助金额:
$ 45.7万 - 项目类别:
Operating Grants
Changes in Natural Killer (NK) Cell Response to Exercise Across Puberty: Determining the Effect of Cell Phenotype and the Systemic Environment
青春期自然杀伤 (NK) 细胞对运动反应的变化:确定细胞表型和全身环境的影响
- 批准号:
552650-2020 - 财政年份:2020
- 资助金额:
$ 45.7万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
A Phase II Study of Cytokine Induced Memory-like (CIML) Natural Killer (NK) Cell Adoptive Therapy after Haploidentical Donor Hematopoietic Cell Transplantation.
单倍相合供体造血细胞移植后细胞因子诱导记忆样 (CIML) 自然杀伤 (NK) 细胞过继治疗的 II 期研究。
- 批准号:
10657635 - 财政年份:2017
- 资助金额:
$ 45.7万 - 项目类别: